Video-assisted thoracoscopic lobectomy: series of consecutive 600 patients in multi-center
10.3760/cma.j.issn.1001-4497.2010.05.006
- VernacularTitle:多中心全胸腔镜肺叶切除手术600例
- Author:
Fan YANG
;
Xiao LI
;
Binhui REN
;
Yuqing HUANG
;
Jun LIU
;
Guanchao JIANG
;
Jianfeng LI
;
Ninglei QIU
;
Yingtai CHEN
;
Jun WANG
;
Lin XU
- Publication Type:Journal Article
- Keywords:
Thorasoscopy;
Pneumonectomy;
Survival analysis
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2010;26(5):307-309,293
- CountryChina
- Language:Chinese
-
Abstract:
Objective To report a multi-center series of 600 consecutive cases of completely video-assisted thoracoscopic lobectomy with 3-year follow-up results. Methods Data from 600 consecutive patients who underwent attempts for thoracoscopic lobectomy between September 2006 and August 2010 in Peking University People's Hospital, Jiangsu Cancer Hospital and Beijing Haidian Hospital were collected. Of these, 315 males (52.5%) and 285 females (47.5%), the average age was ( 59.1 ± 12.6 ) years( 15 - 86 years). Perioperative variables were assessed using standard descriptive statistics and 3-year survival was estimated by Kaplan-Meier analyses. Results One hundred and nineteen cases were diagnosed as benign disease and 481 cases were malignancy. 68.9% (82/119) of the benign cases were chronic infectious disease and the majority of the malignancy was non-small cell lung cancer, especially adenocarcinomas which comprised 65.9% (317/481) of all malignancies.Fifty-four cases required conversion to thoracotomy with a conversion rate of 9%. Of the VATS accomplished group, the median operation time was 180 min(30 -40 min), median blood loss 200 ml( 10 - 1500 ml) . Benign surgery took significantly less time, had shorter drainage time and hospitalization time, and lower morbidity than that for malignancies ( P = 0.001, P ＜0.01, P = 0.004, P = 0.020, respectively). Non-small cell lung cancer patients had a 3 -year survival of 85.4%, and pathologic stage Ⅰ patients 91.2%. Conclusion This largest case series and the first report 3-year survival in China confirms that completely thoracoscopic lobectomy surgery we performed have reached short- and middle-term standards compared with that of the western country.
